Page 1 | Search Results | Diabetes | American Diabetes Association

1-20 of 163

Sort by

Sort Order Select

Meeting Abstracts

169-OR: SGLT2 Inhibitor Prescribing Discrepancies in Patients with Diabetes Mellitus Type 2 and Heart Failure at an Academic Medical Center

JESSICA HANSEN, KRISTEN KULASA, TRICIA SANTOS CAVAIOLA

Diabetes 2023;72(Supplement_1):169-OR

https://doi.org/10.2337/db23-169-OR

Published: 20 June 2023

View article titled, 169-OR: SGLT2 Inhibitor Prescribing Discrepancies in Patients with Diabetes Mellitus Type 2 and Heart Failure at an Academic Medical Center

Meeting Abstracts

272-OR: The Efficacy of Sotagliflozin on Heart-Failure Related Outcomes Is Independent of Baseline A1C

RAHUL AGGARWAL, DEEPAK L. BHATT, MICHAEL SZAREK, MICHAEL J. DAVIES, PHILLIP L. BANKS, BERTRAM PITT, PHILIPPE G. STEG

Diabetes 2023;72(Supplement_1):272-OR

https://doi.org/10.2337/db23-272-OR

Published: 20 June 2023

View article titled, 272-OR: The Efficacy of Sotagliflozin on Heart-Failure Related Outcomes Is Independent of Baseline A1C

Meeting Abstracts

1231-P: Influence of Diabetes on the Progression of Preclinical Stage B Heart Failure Phenotypes to Heart Failure

JUSTIN ECHOUFFO TCHEUGUI, CHIADI E. NDUMELE, SUI ZHANG, KUNIHIRO MATSUSHITA, VIJAY NAMBI, HICHAM SKALI, ELIZABETH SELVIN

Diabetes 2023;72(Supplement_1):1231-P

https://doi.org/10.2337/db23-1231-P

Published: 20 June 2023

View article titled, 1231-P: Influence of Diabetes on the Progression of Preclinical Stage B Heart Failure Phenotypes to Heart Failure

Meeting Abstracts

1230-P: Low Real-World Use of SGLT2 Inhibitors in People with Diabetes and Heart Failure—A Population Cohort Study

SONIA BUTALIA, CHUAN WEN, PETER A. SENIOR, RONALD J. SIGAL, HUDE QUAN, MANH LUAN CHU, PADMA KAUL

Diabetes 2023;72(Supplement_1):1230-P

https://doi.org/10.2337/db23-1230-P

Published: 20 June 2023

View article titled, 1230-P: Low Real-World Use of SGLT2 Inhibitors in People with Diabetes and Heart Failure—A Population Cohort Study

Meeting Abstracts

65-OR: Differences in the Use of Diabetes Medications with Cardiorenal Benefits between Rural and Urban America

KYLE STEIGER, KAVYA SWARNA, JEPH HERRIN, ROZALINA G. MCCOY

Diabetes 2023;72(Supplement_1):65-OR

https://doi.org/10.2337/db23-65-OR

Published: 20 June 2023

View article titled, 65-OR: Differences in the Use of Diabetes Medications with Cardiorenal Benefits between Rural and Urban America

Meeting Abstracts

188-LB: Association between Age at Diagnosis of Type 2 Diabetes and Hospitalization for Heart Failure (HHF)

CALVIN KE, BAIJU R. SHAH, JUSTIN ECHOUFFO TCHEUGUI

Diabetes 2023;72(Supplement_1):188-LB

https://doi.org/10.2337/db23-188-LB

Published: 20 June 2023

View article titled, 188-LB: Association between Age at Diagnosis of Type 2 Diabetes and Hospitalization for Heart Failure (HHF)

Meeting Abstracts

99-LB: Myocardial Blood Flow in Association with Baseline Ejection Fraction after Elevation in Plasma Ketones in Patients with T2DM and Heart Failure

CAROLINA SOLIS-HERRERA, YUEJUAN QIN, HENRI HONKA, FRANCISCA M. ACOSTA, ALEXANDER MOODY, ALBERTO CHAVEZ, CURTIS L. TRIPLITT, GEOFFREY D. CLARKE, EUGENIO CERSOSIMO, RALPH A. DEFRONZO

Diabetes 2023;72(Supplement_1):99-LB

https://doi.org/10.2337/db23-99-LB

Published: 20 June 2023

View article titled, 99-LB: Myocardial Blood Flow in Association with Baseline Ejection Fraction after Elevation in Plasma Ketones in Patients with T2DM and Heart Failure

Meeting Abstracts

1226-P: A Rapid Rate of Kidney Function Decline Is Associated with Increased Risk of Heart Failure in Patients with Type 2 Diabetes—Results from ACCORD Study

ARJOLA BANO, CARLOS BUENO, JUNIOR, YALING TANG, XIUQIN SUN, ELIZABETH HALL, JOANNA MITRI, MARIO LUCA MORIERI, HETAL SHAH, ALESSANDRO DORIA

Diabetes 2023;72(Supplement_1):1226-P

https://doi.org/10.2337/db23-1226-P

Published: 20 June 2023

View article titled, 1226-P: A Rapid Rate of Kidney Function Decline Is Associated with Increased Risk of Heart Failure in Patients with Type 2 Diabetes—Results from ACCORD Study

Meeting Abstracts

1238-P: The Face of Diabetic Cardiomyopathy—Baseline Characteristics from the ARISE-HF Trial

JAVED BUTLER, STEFANO DEL PRATO, JUSTIN EZEKOWITZ, NASRIEN E. IBRAHIM, CAROLYN S. LAM, RICCARDO PERFETTI, JULIO ROSENSTOCK, W.H. WILSON TANG, ALESSIA URBINATI, FAIEZ ZANNAD, JAMES L. JANUZZI

Diabetes 2023;72(Supplement_1):1238-P

https://doi.org/10.2337/db23-1238-P

Published: 20 June 2023

View article titled, 1238-P: The Face of Diabetic Cardiomyopathy—Baseline Characteristics from the ARISE-HF Trial

Meeting Abstracts

450-P: N-Terminal Pro-B Type Natriuretic Peptide Concentrations in Diabetic Cardiomyopathy—Baseline Data from the ARISE-HF Trial

JAVED BUTLER, STEFANO DEL PRATO, JUSTIN EZEKOWITZ, NASRIEN E. IBRAHIM, CAROLYN S. LAM, RICCARDO PERFETTI, JULIO ROSENSTOCK, W.H. WILSON TANG, ALESSIA URBINATI, FAIEZ ZANNAD, JAMES L. JANUZZI, JR.

Diabetes 2023;72(Supplement_1):450-P

https://doi.org/10.2337/db23-450-P

Published: 20 June 2023

View article titled, 450-P: N-Terminal Pro-B Type Natriuretic Peptide Concentrations in Diabetic Cardiomyopathy—Baseline Data from the ARISE-HF Trial

Meeting Abstracts

1352-P: Ethnic Disparities in Diabetic Complications in the U.S.

YILIN YOSHIDA, VIVIAN FONSECA, YUANHAO ZU

Diabetes 2023;72(Supplement_1):1352-P

https://doi.org/10.2337/db23-1352-P

Published: 20 June 2023

View article titled, 1352-P: Ethnic Disparities in Diabetic Complications in the U.S.

Meeting Abstracts

1245-P: Heart Failure Biomarkers in Diabetes—A National Reference Laboratory Study

DAVID ALFEGO, ANDRE VALCOUR, ZAHRA SHAJANI-YI, RANDOLPH M. YOUNG, RENEE M. SULLIVAN

Diabetes 2023;72(Supplement_1):1245-P

https://doi.org/10.2337/db23-1245-P

Published: 20 June 2023

View article titled, 1245-P: Heart Failure Biomarkers in Diabetes—A National Reference Laboratory Study

Meeting Abstracts

1177-P: Maternal Insulin Intervention Improves Offspring Glucose Metabolism via Long Noncoding RNA

QIAN ZHANG, XINHUA XIAO, MING LI

Diabetes 2023;72(Supplement_1):1177-P

https://doi.org/10.2337/db23-1177-P

Published: 20 June 2023

View article titled, 1177-P: Maternal Insulin Intervention Improves Offspring Glucose Metabolism via Long Noncoding RNA

Meeting Abstracts

1011-P: Humanistic and Economic Burden of Patients with Cardiorenal Metabolic Conditions—A Systematic Literature Review

KEITH FERDINAND, KEITH C. NORRIS, HELENA W. RODBARD, JENNIFER TRUJILLO

Diabetes 2023;72(Supplement_1):1011-P

https://doi.org/10.2337/db23-1011-P

Published: 20 June 2023

View article titled, 1011-P: Humanistic and Economic Burden of Patients with Cardiorenal Metabolic Conditions—A Systematic Literature Review

Meeting Abstracts

37-OR: SGLT2 Inhibitors Exert Anti-inflammatory and Antioxidant Effects in Epicardial Adipose Tissue of Severe Heart Failure Subjects

MILOS MRAZ, BARBORA JUDITA KASPEROVA, SONA STEMBERKOVA, PETR SVOBODA, DANIEL HLAVÁCEK, JAKUB MAHRÍK, ONDREJ KUDA, TOMAS CAJKA, LUCIE TOMANOVÁ, IVETA PLEYEROVA, KATERINA ROSOLOVÁ, PETER NOVODVORSKY, PETER IVAK, VOJTECH MELENOVSKY, IVAN NETUKA, MARTIN HALUZIK

Diabetes 2023;72(Supplement_1):37-OR

https://doi.org/10.2337/db23-37-OR

Published: 20 June 2023

View article titled, 37-OR: SGLT2 Inhibitors Exert Anti-inflammatory and Antioxidant Effects in Epicardial Adipose Tissue of Severe Heart Failure Subjects

Meeting Abstracts

873-P: Empagliflozin Compliance and Influencing Factors in Patients with Heart Failure and Diabetes

CARLOS A. ALVAREZ, AARON PERKINS, MEREDITH A. SIGLER, HUI YANG, HARJEET CABERWAL, RAMIN EBRAHIMI

Diabetes 2023;72(Supplement_1):873-P

https://doi.org/10.2337/db23-873-P

Published: 20 June 2023

View article titled, 873-P: Empagliflozin Compliance and Influencing Factors in Patients with Heart Failure and Diabetes

Meeting Abstracts

895-P: External Validation of the BRAVO Diabetes Model Using Data from the EXSCEL Study

YIXUE SHAO, SHU NIU, LIZHENG SHI, VIVIAN FONSECA, HUI SHAO

Diabetes 2022;71(Supplement_1):895-P

https://doi.org/10.2337/db22-895-P

Published: 01 June 2022

View article titled, 895-P: External Validation of the BRAVO Diabetes Model Using Data from the EXSCEL Study

Meeting Abstracts

121-LB: Prescribing Patterns of Sodium–Glucose Cotransporter 2 Inhibitors in Patients with Heart Failure With or Without Type 2 Diabetes

SARAH R. BERMUDEZ, JOE R. ANDERSON, GRETCHEN RAY

Diabetes 2022;71(Supplement_1):121-LB

https://doi.org/10.2337/db22-121-LB

Published: 01 June 2022

View article titled, 121-LB: Prescribing Patterns of Sodium–Glucose Cotransporter 2 Inhibitors in Patients with Heart Failure With or Without Type 2 Diabetes

Meeting Abstracts

1081-P: Blood Pressure Variability Is Associated with Risk of Heart Failure, Elevated NT-proBNP, and High-Sensitivity Troponin: Results from MESA

DANIEL S. NUYUJUKIAN, JIN ZHOU, JURAJ KOSKA, CHIKE NWABUO, ALAIN BERTONI, STEVEN SHEA, PETER REAVEN

Diabetes 2022;71(Supplement_1):1081-P

https://doi.org/10.2337/db22-1081-P

Published: 01 June 2022

View article titled, 1081-P: Blood Pressure Variability Is Associated with Risk of Heart Failure, Elevated NT-proBNP, and High-Sensitivity Troponin: Results from MESA

Meeting Abstracts

1148-P: Risk Factor Control and Risk of Hospitalization for Heart Failure in Diabetic Patients

HAO MA, XUAN WANG, YORIKO HEIANZA, LU QI

Diabetes 2022;71(Supplement_1):1148-P

https://doi.org/10.2337/db22-1148-P

Published: 01 June 2022

View article titled, 1148-P: Risk Factor Control and Risk of Hospitalization for Heart Failure in Diabetic Patients

NARROW

169-OR: SGLT2 Inhibitor Prescribing Discrepancies in Patients with Diabetes Mellitus Type 2 and Heart Failure at an Academic Medical Center

272-OR: The Efficacy of Sotagliflozin on Heart-Failure Related Outcomes Is Independent of Baseline A1C

1231-P: Influence of Diabetes on the Progression of Preclinical Stage B Heart Failure Phenotypes to Heart Failure

1230-P: Low Real-World Use of SGLT2 Inhibitors in People with Diabetes and Heart Failure—A Population Cohort Study

65-OR: Differences in the Use of Diabetes Medications with Cardiorenal Benefits between Rural and Urban America

188-LB: Association between Age at Diagnosis of Type 2 Diabetes and Hospitalization for Heart Failure (HHF)

99-LB: Myocardial Blood Flow in Association with Baseline Ejection Fraction after Elevation in Plasma Ketones in Patients with T2DM and Heart Failure

1226-P: A Rapid Rate of Kidney Function Decline Is Associated with Increased Risk of Heart Failure in Patients with Type 2 Diabetes—Results from ACCORD Study

1238-P: The Face of Diabetic Cardiomyopathy—Baseline Characteristics from the ARISE-HF Trial

450-P: N-Terminal Pro-B Type Natriuretic Peptide Concentrations in Diabetic Cardiomyopathy—Baseline Data from the ARISE-HF Trial

1352-P: Ethnic Disparities in Diabetic Complications in the U.S.

1245-P: Heart Failure Biomarkers in Diabetes—A National Reference Laboratory Study

1177-P: Maternal Insulin Intervention Improves Offspring Glucose Metabolism via Long Noncoding RNA

1011-P: Humanistic and Economic Burden of Patients with Cardiorenal Metabolic Conditions—A Systematic Literature Review

37-OR: SGLT2 Inhibitors Exert Anti-inflammatory and Antioxidant Effects in Epicardial Adipose Tissue of Severe Heart Failure Subjects

873-P: Empagliflozin Compliance and Influencing Factors in Patients with Heart Failure and Diabetes

895-P: External Validation of the BRAVO Diabetes Model Using Data from the EXSCEL Study

121-LB: Prescribing Patterns of Sodium–Glucose Cotransporter 2 Inhibitors in Patients with Heart Failure With or Without Type 2 Diabetes

1081-P: Blood Pressure Variability Is Associated with Risk of Heart Failure, Elevated NT-proBNP, and High-Sensitivity Troponin: Results from MESA

1148-P: Risk Factor Control and Risk of Hospitalization for Heart Failure in Diabetic Patients

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

This Feature Is Available To Subscribers Only